StreetInsider.com News Articles

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)-- Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision, today announced that the company will present at the Eye Bank Association of America (EBAA) 2026 Annual Meeting, taking place in Indianapolis, Indiana, from June 3-6 and at the American-European Congress of Ophthalmic Surgery (AECOS) 2026 European Symposium, June 11-14 in Madrid, Spain.

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June

Thu, 28 May 2026 16:30:00 -0400

Aurion has been invited for the first time to participate in a panel discussion at EBAA, focused on Innovative Solutions in

Form SD ALCON INC

Fri, 15 May 2026 11:12:00 -0400

si-local-file:///var/storage/secattach/20260515/26502007.html

Form SD ALCON INC

Fri, 15 May 2026 11:12:00 -0400

si-local-file:///var/storage/secattach/20260515/26502007.html

Form SD ALCON INC

Fri, 15 May 2026 11:12:00 -0400

si-local-file:///var/storage/secattach/20260515/26502007.html

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF70 at Deutsche Bank

Tue, 12 May 2026 04:45:17 -0400

Deutsche Bank analyst Falko Friedrichs lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF70.00 (from CHF77.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF70 at Deutsche Bank

Tue, 12 May 2026 04:45:17 -0400

Deutsche Bank analyst Falko Friedrichs lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF70.00 (from CHF77.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF70 at Deutsche Bank

Tue, 12 May 2026 04:45:17 -0400

Deutsche Bank analyst Falko Friedrichs lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF70.00 (from CHF77.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF70 at Deutsche Bank

Tue, 12 May 2026 04:45:17 -0400

Deutsche Bank analyst Falko Friedrichs lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF70.00 (from CHF77.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF71 at Goldman Sachs

Mon, 11 May 2026 03:04:40 -0400

Goldman Sachs analyst Richard Felton lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF71.00 (from CHF82.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF71 at Goldman Sachs

Mon, 11 May 2026 03:04:40 -0400

Goldman Sachs analyst Richard Felton lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF71.00 (from CHF82.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF71 at Goldman Sachs

Mon, 11 May 2026 03:04:40 -0400

Goldman Sachs analyst Richard Felton lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF71.00 (from CHF82.00) while maintaining a Buy rating.

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF71 at Goldman Sachs

Mon, 11 May 2026 03:04:40 -0400

Goldman Sachs analyst Richard Felton lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF71.00 (from CHF82.00) while maintaining a Buy rating.

Algoma Central shareholders elect 10 directors at annual meeting

Fri, 08 May 2026 16:34:28 -0400

Algoma Central Corporation (TSX: ALC) held its annual general meeting of shareholders on May 7, 2026, according to a company statement.

Shareholders elected all 10 nominated directors to serve until the next annual meeting. The directors received support from 77.54% of shares voted, with individual candidates receiving between 99.4% and 99.7% approval rates.

The elected directors are Mats H. Berglund, Richard B. Carty, Jens Grønning, E.M. Blake Hutcheson, Duncan N.R. Jackman, Trinity O. Jackman, Mark McQueen, Clive P. Rowe, Gregg A. Ruhl, and Eric Stevenson.

Shareholders also approved the appointment of Deloitte LLP as the company's independent auditors. The auditor appointment received 99.7%

Algoma Central shareholders elect 10 directors at annual meeting

Fri, 08 May 2026 16:34:28 -0400

Algoma Central Corporation (TSX: ALC) held its annual general meeting of shareholders on May 7, 2026, according to a company statement.

Shareholders also approved the appointment of Deloitte LLP as the company's independent auditors. The auditor appointment received 99.7%